期刊文献+

Growth differentiation factor-15 serum concentrations reflect disease severity and anemia in patients with inflammatory bowel disease

下载PDF
导出
摘要 BACKGROUND Population of patients with inflammatory bowel disease(IBD)is burdened by various extraintestinal manifestations which substantially contribute to greater morbidity and mortality.Growth-differentiation factor-15(GDF-15)is often overexpressed under stress conditions,such as inflammation,malignancies,heart failure,myocardial ischemia,and many others.AIM To explore the association between GDF-15 and IBD as serum concentrations of GDF-15 were shown to be an independent predictor of poor outcomes in multiple diseases.An additional aim was to determine possible associations between GDF-15 and multiple clinical,anthropometric and laboratory parameters in patients with IBD.METHODS This cross-sectional study included 90 adult patients diagnosed with IBD,encompassing both Crohn’s disease(CD)and ulcerative colitis(UC),and 67 healthy age-and sex-matched controls.All patients underwent an extensive workup,including colonoscopy with subsequent histopathological analysis.Disease activity was assessed by two independent gastroenterology consultants specialized in IBD,employing well-established clinical and endoscopic scoring systems.GDF-15 serum concentrations were determined following an overnight fasting,using electrochemiluminescence immunoassay.RESULTS In patients with IBD,serum GDF-15 concentrations were significantly higher in comparison to the healthy controls[800(512-1154)pg/mL vs 412(407-424)pg/mL,P<0.001],whereas no difference in GDF-15 was found between patients with CD and UC[807(554-1451)pg/mL vs 790(509-956)pg/mL,P=0.324].Moreover,multiple linear regression analysis showed that GDF-15 levels predict CD and UC severity independent of age,sex,and C-reactive protein levels(P=0.016 and P=0.049,respectively).Finally,an association between GDF-15 and indices of anemia was established.Specifically,negative correlations were found between GDF-15 and serum iron levels(r=-0.248,P=0.021),as well as GDF-15 and hemoglobin(r=-0.351,P=0.021).Accordingly,in comparison to IBD patients with normal hemoglobin levels,GDF-
出处 《World Journal of Gastroenterology》 SCIE CAS 2024年第13期1899-1910,共12页 世界胃肠病学杂志(英文版)
  • 相关文献

参考文献5

二级参考文献34

  • 1Ulas D Bayraktar,Soley Bayraktar.Treatment of iron deficiency anemia associated with gastrointestinal tract diseases[J].World Journal of Gastroenterology,2010,16(22):2720-2725. 被引量:13
  • 2Jia Zhao,Rushil Randive,James A Stewart.Molecular mechanisms of AGE/RAGE-mediated fibrosis in the diabetic heart[J].World Journal of Diabetes,2014,5(6):860-867. 被引量:18
  • 3Simon Siu-Man Ng,Janet Fung-Yee Lee,Raymond Ying-Chang Yiu,Jimmy Chak-Man Li,Sophie Sok-Fei Hon.Telerobotic-assisted laparoscopic abdominoperineal resection for low rectal cancer: Report of the first case in Hong Kong and China with an updated literature review[J].World Journal of Gastroenterology,2007,13(17):2514-2518. 被引量:13
  • 4Fernando Gomollón,Javier P. Gisbert.Current Management of Iron Deficiency Anemia in Inflammatory Bowel Diseases: A Practical Guide[J]. Drugs . 2013 (16) 被引量:2
  • 5Michael Auerbach,William Strauss,Sarah Auerbach,Stella Rineer,Huzefa Bahrain.Safety and efficacy of total dose infusion of 1,020 mg of ferumoxytol administered over 15 min[J]. Am. J. Hematol. . 2013 (11) 被引量:2
  • 6D. Wayne Thomas,Rod F. Hinchliffe,Carol Briggs,Iain C. Macdougall,Tim Littlewood,Ivor Cavill.Guideline for the laboratory diagnosis of functional iron deficiency[J]. Br J Haematol . 2013 (5) 被引量:2
  • 7Walter Reinisch,Michael Staun,Sunil Bhandari,Manuel Mu?oz.State of the iron: How to diagnose and efficiently treat iron deficiency anemia in inflammatory bowel disease[J]. Journal of Crohn’s and Colitis . 2012 被引量:2
  • 8Asma Khalil,James R. Goodhand,Mahmood Wahed,Jayne Yeung,F. Runa Ali,David S. Rampton.Efficacy and tolerability of intravenous iron dextran and oral iron in inflammatory bowel disease: a case-matched study in clinical practice[J]. European Journal of Gastroenterology & Hepatology . 2011 (11) 被引量:1
  • 9Rayko Evstatiev,Philippe Marteau,Tariq Iqbal,Igor L. Khalif,Jürgen Stein,Bernd Bokemeyer,Ivan V. Chopey,Florian S. Gutzwiller,Lise Riopel,Christoph Gasche.FERGIcor, a Randomized Controlled Trial on Ferric Carboxymaltose for Iron Deficiency Anemia in Inflammatory Bowel Disease[J]. Gastroenterology . 2011 (3) 被引量:1
  • 10A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer?), a new intravenous iron preparation and its clinical implications[J]. European Journal of Pharmaceutics and Biopharmaceutics . 2011 (3) 被引量:1

共引文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部